The global Animal Peptides Market is entering a phase of accelerated expansion, supported by rapid advancements in precision nutrition, functional feed technologies, and therapeutic veterinary formulations.
According to the latest projections, the market is expected to grow from USD 900.2 million in 2025 to USD 2,556.0 million by 2035, registering a robust CAGR of 11.0% over the decade. This reflects a substantial increase of more than USD 1.65 billion, signaling a transformative shift in the adoption of animal-derived bioactive peptides across the nutraceutical, veterinary, and biopharmaceutical sectors.
Explore trends before investing – request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-26121
Strong Decade Outlook with Shifting Value Toward High-Purity Peptides
Between 2025 and 2030, the market is anticipated to climb to USD 1,518.6 million, contributing nearly 38% of total decade growth. This period will be defined by broadened uptake of collagen and milk-derived peptides in functional foods and animal wellness products, strengthened by rising consumer trust and regulatory support for natural bioactive ingredients.
Growth is expected to accelerate between 2030 and 2035, adding an additional USD 1,037.4 million—equivalent to 62% of total forecast expansion. Advanced enzymatic processing, recombinant peptide production, and the emergence of precision hydrolysates are set to redefine premium product categories. Animal peptides are projected to transition from niche additives into mainstream health and performance solutions for both livestock and companion animals.
Market Momentum Rooted in Antibiotic-Free Strategies and Preventive Animal Health
Global efforts to reduce antibiotic usage in food animals continue to be a major driver. Functional peptides with immunomodulatory and antimicrobial properties are increasingly being viewed as viable and sustainable alternatives to antibiotic growth promoters. Their growing relevance in enhancing gut integrity, nutrient absorption, and disease resilience is reinforcing adoption across poultry, ruminants, swine, and aquaculture.
In companion animal nutrition, rapid pet humanization trends are pushing demand for cosmeceutical-grade peptides, with a growing emphasis on joint health, mobility, skin vitality, and digestive wellness. As veterinary care shifts toward preventive and functional nutrition, injectables and microencapsulated peptide formats are gaining traction.
Powder Segment Leads with 58.3% Share, While Advanced Formats Gain Pace
Powders are expected to dominate with 58.3% share in 2025, owing to cost efficiency, formulation versatility, and widespread integration into feed and supplement premixes. However, encapsulated actives and injectable peptides are emerging as the fastest-growing categories, aligned with rising demand for targeted delivery and species-specific therapeutic outcomes.
Poultry Emerges as Leading Species Segment
Poultry is projected to account for 27.3% of total market value in 2025. The segment benefits from the intensive nature of broiler and layer operations, where peptides are used for feed conversion, immune support, and gut performance. Ruminants and swine collectively capture more than 40%, while companion animals continue to deliver the highest margins as premium peptide-based health solutions proliferate.
Geographical Trends Highlight Strong Growth in Asia-Pacific and Europe
Top-performing countries (CAGR 2025–2035):
- India: 13.2%
- Brazil: 12.6%
- UK: 12.1%
- China: 11.4%
- USA: 11.1%
- Germany: 10.6%
- France: 10.0%
India’s rapid livestock industrialization and aquaculture expansion are catalyzing peptide use in performance feeds. China continues scaling antimicrobial peptides and enzymatic hydrolysates for antibiotic-free production. Meanwhile, Europe’s stringent sustainability and traceability mandates are enabling broader integration of functional peptides in dairy, swine, and premium pet food categories.
In the United States, the market is projected to advance from USD 239.1 million in 2025 to USD 685.8 million by 2035, driven by therapeutic veterinary applications and expanding specialty pet nutrition portfolios.
Competitive Landscape Shifts Toward Precision Peptide Solutions
The market remains moderately fragmented, led by established collagen suppliers such as PB Leiner, Gelita AG, Rousselot, and Nitta Gelatin Inc. Mid-sized players including Titan Biotech and Weishardt International are strengthening regional presence through cost-effective hydrolysates and application-specific blends.
Niche companies—such as CPC Scientific, Bachem AG, and VPEP India Pvt. Ltd.—are propelling innovation with recombinant peptides, encapsulated actives, and veterinary injectables, positioning themselves at the forefront of high-value peptide therapeutics.
Outlook
With expanding scientific validation, evolving regulatory clarity, and rising demand for biologically functional and sustainable ingredients, the Animal Peptides Market is poised to become a central pillar of next-generation animal nutrition and veterinary care. As precision health strategies take hold globally, peptides are expected to unlock new pathways for performance, resilience, and therapeutic innovation across the entire animal ecosystem.
